Frank Pasqualone is of Enveric Biosciences, Inc.. Currently has a direct ownership of 7,904 shares of ENVB, which is worth approximately $41,733. The most recent transaction as insider was on Dec 23, 2025, when has been sold 7,633 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.9K
83.78% 3M change
83.78% 12M change
Total Value Held $41,733

FRANK PASQUALONE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2025
BUY
Grant, award, or other acquisition
-
7,633 Added 49.13%
7,904 Common Stock
Oct 09 2024
BUY
Grant, award, or other acquisition
-
47,733 Added 49.48%
48,733 Common Stock
Sep 15 2023
BUY
Open market or private purchase
$2,140 $2.14 p/Share
1,000 Added 50.0%
1,000 Common Stock

Also insider at

TBPH
Theravance Biopharma, Inc. Healthcare
FP

Frank Pasqualone

South San Francisco, CA

Track Institutional and Insider Activities on ENVB

Follow Enveric Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENVB shares.

Notify only if

Insider Trading

Get notified when an Enveric Biosciences, Inc. insider buys or sells ENVB shares.

Notify only if

News

Receive news related to Enveric Biosciences, Inc.

Track Activities on ENVB